Lesbian Cancer leader and Herceptin Heroine loses drug funding battle

First reported on LGBT Cancer on April 2, 2008, http://lgbtcancer.com/chris-walsh-lesbian-health-campaigner-wins-victory-for-herceptin-financing/

Pharmac has decided not to increase its funding of the breast cancer fighting drug Herceptin, despite a legal challenge by eight breast cancer patients, dubbed the ‘Herceptin Heroines’, who include lesbian health campaigner Chris Walsh.

Two years ago, the government drug funding agency decided against spending up to $30 million a year for the 12-month Herceptin programme for women with the aggressive HER2 positive form of breast cancer. http://www.gaynz.com/articles/publish/2/article_6319.php